Published in J Transl Med on September 27, 2011
Modulating the vascular response to limb ischemia: angiogenic and cell therapies. Circ Res (2015) 0.94
Long-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injury. Invest Ophthalmol Vis Sci (2012) 0.93
Autologous bone marrow cell therapy for peripheral arterial disease. Stem Cells Cloning (2012) 0.85
Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial. Cytotherapy (2014) 0.81
Clinical trials of adult stem cell therapy for peripheral artery disease. Methodist Debakey Cardiovasc J (2013) 0.80
Bone marrow aspirate injection for treatment of critical limb ischemia with comparison to patients undergoing high-risk bypass grafts. J Vasc Surg (2014) 0.79
Stem cell trials for cardiovascular medicine: ethical rationale. Tissue Eng Part A (2013) 0.79
From bench to bedside: review of gene and cell-based therapies and the slow advancement into phase 3 clinical trials, with a focus on Aastrom's Ixmyelocel-T. Stem Cell Rev (2013) 0.77
Therapeutic Efficacy of Stem Cell-based Therapy in Peripheral Arterial Disease: A Meta-Analysis. PLoS One (2015) 0.76
Avoidance of lower-limb amputation by surgical implantation of autologous stem cells. Proc (Bayl Univ Med Cent) (2013) 0.75
Safety and Effectiveness of Bone Marrow Cell Concentrate in the Treatment of Chronic Critical Limb Ischemia Utilizing a Rapid Point-of-Care System. Stem Cells Int (2017) 0.75
Long-Term Follow-up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia. J Am Heart Assoc (2017) 0.75
Cell Therapy and Critical Limb Ischemia: Evidence and Window of Opportunity in Obesity. Obes Control Ther (2016) 0.75
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg (2007) 14.17
Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet (2005) 7.25
Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet (2011) 2.88
National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg (2009) 2.55
Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol Ther (2008) 2.13
Trends, complications, and mortality in peripheral vascular surgery. J Vasc Surg (2006) 1.72
Effects of spinal cord stimulation (SCS) in patients with inoperable severe lower limb ischaemia: a prospective randomised controlled study. Eur J Vasc Endovasc Surg (1995) 1.52
Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg (2008) 1.47
Predictors of limb loss despite a patent endovascular-treated arterial segment. J Vasc Surg (2009) 1.45
Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease. Cell Transplant (2009) 1.40
Clinical outcome and its predictors in 1560 patients with critical leg ischaemia. Chronic Critical Leg Ischaemia Group. Eur J Vasc Endovasc Surg (1999) 1.21
Outcome of unreconstructed chronic critical leg ischaemia. Eur J Vasc Endovasc Surg (1996) 1.14
Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia. J Vasc Surg (2011) 1.13
Understanding objective performance goals for critical limb ischemia trials. Semin Vasc Surg (2010) 1.13
Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. J Vasc Surg (2006) 1.11
Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial. J Vasc Surg (2010) 1.10
Comparison of interventional outcomes according to preoperative indication: a single center analysis of 2,240 limb revascularizations. J Am Coll Surg (2009) 1.07
Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer. Cell Transplant (2010) 1.06
Finnvasc score and modified Prevent III score predict long-term outcome after infrainguinal surgical and endovascular revascularization for critical limb ischemia. J Vasc Surg (2010) 0.94
Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularization for critical lower-limb ischemia: a Finnvasc registry study. World J Surg (2007) 0.93
Resource utilization in the treatment of critical limb ischemia: The effect of tissue loss, comorbidities, and graft-related events. J Vasc Surg (2006) 0.90
Spinal cord stimulation in the treatment of non-reconstructable stable critical leg ischaemia: results of the European Peripheral Vascular Disease Outcome Study (SCS-EPOS). Eur J Vasc Endovasc Surg (2003) 0.88
Spinal-cord stimulation in critical limb ischaemia: a randomised trial. ESES Study Group. Lancet (1999) 0.84
A prognostic model for amputation in critical lower limb ischemia. Vasc Med (2009) 0.80
Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg (2006) 3.38
Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J Vasc Surg (2003) 2.71
Acute aortic dissection: population-based incidence compared with degenerative aortic aneurysm rupture. Mayo Clin Proc (2004) 2.55
Splenic artery aneurysms: two decades experience at Mayo clinic. Ann Vasc Surg (2002) 2.51
Establishing a protocol for endovascular treatment of ruptured abdominal aortic aneurysms: outcomes of a prospective analysis. J Vasc Surg (2006) 2.11
Contemporary management of acute mesenteric ischemia: Factors associated with survival. J Vasc Surg (2002) 1.90
Long-term outcomes of secondary procedures after endovascular aneurysm repair. J Vasc Surg (2010) 1.88
Disparity in outcomes of surgical revascularization for limb salvage: race and gender are synergistic determinants of vein graft failure and limb loss. Circulation (2008) 1.80
HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells. Arterioscler Thromb Vasc Biol (2002) 1.78
Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc (2002) 1.74
Management strategies for asymptomatic carotid stenosis: a systematic review and meta-analysis. Ann Intern Med (2013) 1.67
The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vasc Surg (2008) 1.67
Strategies to improve spinal cord ischemia in endovascular thoracic aortic repair: Outcomes of a prospective cerebrospinal fluid drainage protocol. J Vasc Surg (2008) 1.66
Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg (2002) 1.64
The Society for Vascular Surgery Practice Guidelines: management of the left subclavian artery with thoracic endovascular aortic repair. J Vasc Surg (2009) 1.63
Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med (2009) 1.62
Outcomes before and after initiation of an acute aortic treatment center. J Vasc Surg (2010) 1.56
Limitations in the cardiac risk reduction provided by coronary revascularization prior to elective vascular surgery. J Vasc Surg (2002) 1.56
Optimal medical management of peripheral arterial disease. Vasc Endovascular Surg (2006) 1.55
Twenty-year analysis of trends in the incidence and in-hospital mortality for lower-extremity arterial thromboembolism. Circulation (2013) 1.49
Efficacy of duplex ultrasound surveillance after infrainguinal vein bypass may be enhanced by identification of characteristics predictive of graft stenosis development. J Vasc Surg (2008) 1.49
Relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham heart study. Circulation (2010) 1.47
Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg (2008) 1.47
Current efficacy of open and endovascular interventions for advanced superficial femoral artery occlusive disease. J Vasc Surg (2013) 1.43
Asymptomatic carotid artery stenosis treated with medical therapy alone: temporal trends and implications for risk assessment and the design of future studies. Cerebrovasc Dis (2014) 1.42
Magnetic resonance angiography minimizes need for arteriography after inadequate carotid duplex ultrasound scanning. J Vasc Surg (2003) 1.42
What is the learning curve for carotid artery stenting with neuroprotection? Analysis of 200 consecutive cases at an academic institution. Perspect Vasc Surg Endovasc Ther (2005) 1.41
Does sac size matter? Findings based on surgical exploration of excluded abdominal aortic aneurysms. J Endovasc Ther (2005) 1.39
Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Med Sci Monit (2005) 1.37
Popliteal artery entrapment syndrome: role of imaging in the diagnosis. AJR Am J Roentgenol (2003) 1.36
Management of carotid body paragangliomas and review of a 30-year experience. Ann Vasc Surg (2002) 1.36
Surgery remains the most effective treatment for Paget-Schroetter syndrome: 50 years' experience. Ann Thorac Surg (2008) 1.32
Endovascular repair of ruptured infrarenal abdominal aortic aneurysm is associated with lower 30-day mortality and better 5-year survival rates than open surgical repair. J Vasc Surg (2012) 1.29
Vascular injuries associated with elective orthopedic procedures. Ann Vasc Surg (2003) 1.29
Current results of open revascularization for chronic mesenteric ischemia: a standard for comparison. J Vasc Surg (2002) 1.29
Plaque excision with the Silverhawk catheter: early results in patients with claudication or critical limb ischemia. J Vasc Surg (2007) 1.28
Allogeneic endometrial regenerative cells: an "Off the shelf solution" for critical limb ischemia? J Transl Med (2008) 1.27
Factors associated with abdominal compartment syndrome complicating endovascular repair of ruptured abdominal aortic aneurysms. J Vasc Surg (2005) 1.27
Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg (2005) 1.26
The coalition to reduce racial and ethnic disparities in cardiovascular disease outcomes (credo): why credo matters to cardiologists. J Am Coll Cardiol (2011) 1.25
An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc Endovascular Surg (2005) 1.23
Improved outcomes in the recent management of secondary aortoenteric fistula. J Vasc Surg (2005) 1.22
A historical prospective cohort study of carotid artery stenosis after radiotherapy for head and neck malignancies. Int J Radiat Oncol Biol Phys (2005) 1.20
Prospective evaluation of endoluminal venous stents in the treatment of the May-Thurner syndrome. Ann Vasc Surg (2002) 1.20
Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy. Cell Immunol (2010) 1.19
Effects of bilateral hypogastric artery interruption during endovascular and open aortoiliac aneurysm repair. J Vasc Surg (2004) 1.18
A prospective evaluation of hypogastric artery embolization in endovascular aortoiliac aneurysm repair. J Vasc Surg (2002) 1.16
Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res (2005) 1.16
Carotid artery stenting with neuroprotection: assessing the learning curve and treatment outcome. Am J Surg (2005) 1.15
Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia. J Vasc Surg (2011) 1.13
Implications of in situ thrombosis and distal embolization during superficial femoral artery endoluminal intervention. Ann Vasc Surg (2009) 1.11
Images in clinical medicine. Abdominal aortic aneurysm as an incidental finding. N Engl J Med (2003) 1.11
Skeletal muscle BOLD MRI: from underlying physiological concepts to its usefulness in clinical conditions. J Magn Reson Imaging (2012) 1.10
Trends in rehabilitation after amputation for geriatric patients with vascular disease: implications for future health resource allocation. Arch Phys Med Rehabil (2002) 1.10
Feasibility investigation of allogeneic endometrial regenerative cells. J Transl Med (2009) 1.10
Covered stent exclusion of dialysis access pseudoaneurysms. J Surg Res (2002) 1.10
Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report. Int Arch Med (2010) 1.09
Carotid body tumors. J Am Coll Surg (2002) 1.09
Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: an analysis of 1404 operations for critical limb ischemia. J Vasc Surg (2007) 1.09
The long-term outcomes of percutaneous therapy for renal artery fibromuscular dysplasia. J Vasc Surg (2008) 1.08
Ultrasound criteria for severe in-stent restenosis following carotid artery stenting. J Vasc Surg (2008) 1.08
Pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis: safety and feasibility study. J Vasc Surg (2004) 1.07
Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg (2007) 1.07
Nitrotyrosine and chlorotyrosine: clinical significance and biological functions in the vascular system. J Surg Res (2005) 1.06
Effects of 5 HIV protease inhibitors on vasomotor function and superoxide anion production in porcine coronary arteries. J Acquir Immune Defic Syndr (2005) 1.06
Carotid artery aneurysm: evolution of management over two decades. J Vasc Surg (2006) 1.05
Iliac artery kinking with endovascular therapies: technical considerations. J Vasc Interv Radiol (2002) 1.04
Outcome of aggressive surveillance colonoscopy in ruptured abdominal aortic aneurysm. J Vasc Surg (2004) 1.04
Management of thrombosed dialysis access: thrombectomy versus thrombolysis. Semin Vasc Surg (2004) 1.03
Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg (2006) 1.03
Hiv Tat protein causes endothelial dysfunction in porcine coronary arteries. J Vasc Surg (2003) 1.03
Management of in-sent restenosis after carotid artery stenting in high-risk patients. J Vasc Surg (2006) 1.02
Effects of TNF-alpha and curcumin on the expression of thrombomodulin and endothelial protein C receptor in human endothelial cells. Thromb Res (2004) 1.02
In situ reconstruction with cryopreserved arterial allografts for management of mycotic aneurysms or aortic prosthetic graft infections: a multi-institutional experience. Tex Heart Inst J (2006) 1.02
Review: application of stem cells for vascular tissue engineering. Tissue Eng (2005) 1.02
Comparison of hemodynamics in the ascending aorta between pulsatile and continuous flow left ventricular assist devices using computational fluid dynamics based on computed tomography images. Artif Organs (2013) 1.01
Adipocyte-derived cytokine resistin causes endothelial dysfunction of porcine coronary arteries. J Vasc Surg (2005) 1.01
Carotid-carotid crossover bypass: is it a durable procedure? J Vasc Surg (2003) 1.01
Clinical use and molecular mechanisms of action of extract of Ginkgo biloba leaves in cardiovascular diseases. Cardiovasc Drug Rev (2004) 1.01
Chlamydia pneumoniae and vascular disease: an update. J Vasc Surg (2006) 1.00
Molecular mechanisms and clinical applications of ginseng root for cardiovascular disease. Med Sci Monit (2004) 1.00
Hybrid approach to complex thoracic aortic aneurysms in high-risk patients: surgical challenges and clinical outcomes. J Vasc Surg (2006) 1.00
Iliac vein stenting for chronic venous insufficiency. Tex Heart Inst J (2007) 0.99
Critical analysis of outcome determinants affecting repair of intact aneurysms involving the visceral aorta. Ann Vasc Surg (2005) 0.98
Paget-Schroetter syndrome therapy: failure of intravenous stents. Ann Thorac Surg (2003) 0.98
Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation (2014) 0.98
Systematic review of outcomes after surgical management of venous disease incorporating subfascial endoscopic perforator surgery. J Vasc Surg (2004) 0.98
HIV protease inhibitor ritonavir decreases endothelium-dependent vasorelaxation and increases superoxide in porcine arteries. Cardiovasc Res (2004) 0.98
Roles of hemodynamic forces in vascular cell differentiation. Ann Biomed Eng (2005) 0.98
Management of venous leg ulcers: clinical practice guidelines of the Society for Vascular Surgery ® and the American Venous Forum. J Vasc Surg (2014) 0.98
Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure. Vasc Endovascular Surg (2005) 0.98
Ginsenoside Rb1 blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. J Vasc Surg (2005) 0.97
Safety and efficacy of autologous cell therapy in critical limb ischemia: a systematic review. Cell Transplant (2012) 0.97
Influence of LVAD cannula outflow tract location on hemodynamics in the ascending aorta: a patient-specific computational fluid dynamics approach. ASAIO J (2012) 0.97
Surgical treatment of internal carotid artery occlusion. J Vasc Surg (2003) 0.97
Guidelines for the treatment of arterial insufficiency ulcers. Wound Repair Regen (2007) 0.97